SIGN UP
LOG IN
MARKET
ELV
ELV
Elevance Health Inc
NYSE
483.12
+3.63
+0.76%
After Hours: 485.24 +2.12 +0.44% 16:47 12/01 EST
OPEN
478.42
PREV CLOSE
479.49
HIGH
485.22
LOW
478.42
VOLUME
1.36M
TURNOVER
0
52 WEEK HIGH
544.01
52 WEEK LOW
410.63
MARKET CAP
113.51B
P/E (TTM)
18.97
1D
5D
1M
3M
1Y
5Y
Elevance Health, Inc.'s (NYSE:ELV) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Elevance health's (nyse:elv) stock increased by 9.2% over the past three months. Elevance health has a 16% return on equity, compared to an industry average of 11%. The company's net income growth of 9.6% is moderate compared to the industry's average growth rate of 10.0%. Return on equity is the rate of earnings growth of a company based on its annual profit.
Simply Wall St · 1d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of December 3
Home dividends analysis weekly summary of dividend champions, contenders, and challengers. This week's list includes companies which have increased their annual dividend payouts. Companies on the list have changed their dividends in the past week. These stocks have the chance to be eligible for the upcoming dividend increases.
Seeking Alpha · 1d ago
Elevance Health (ELV) Outperforms Broader Market: What You Need to Know
NASDAQ · 2d ago
Elevance Health Inc: Statement of changes in beneficial ownership of securities
Press release · 2d ago
Ex-Dividend Reminder: Sempra, The Cigna Group and Elevance Health
NASDAQ · 3d ago
Elevance Health Inc: Report of proposed sale of securities
Press release · 3d ago
Experts see Cigna, Humana pulling off merger, despite antitrust concerns
Experts see cigna, humana pulling off merger, despite antitrust concerns. Wall street journal reported wednesday that the two companies are in merger talks. A potential merger would likely face scrutiny over their clout in the medicare advantage and pbm markets. Both companies have said they are looking to divest certain assets to avoid antitrust scrutiny.
Seeking Alpha · 3d ago
Cigna-Humana M&A deal likely to take over 12 months to close: analysts
Cigna-humana m&a deal likely to take over 12 months to close: jpmorgan and bank of america analysts. Wall street journal reports that cigna and humana are in talks for a potential merger deal. Jpmorgan analyst sees regulatory headwinds and expects the deal to take 12–24 months.
Seeking Alpha · 4d ago
About ELV
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. Carelon Services offers a broad array of healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.
Webull offers Elevance Health Inc stock information, including NYSE: ELV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading ELV stock methods without spending real money on the virtual paper trading platform.